Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion
Brief Summary
Propofol is a popular intravenous drug to induce anesthesia but it causes local pain with an incidence between 40 and 90%. Three different strategies to prevent propofol induced pain will be studied compared with placebo. Pain will be scored with a four-point scale.
Intervention / Treatment
-
kétamine 20mg (DRUG)N/A
-
ephedrine 3mg (DRUG)N/A
-
lidocaine 40mg (DRUG)N/A
Condition or Disease
- Induction of Total Intravenous General Anesthesia
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Unknown status |
Study results: | No Results Available |
Age: | 18 Years to 75 Years |
Enrollment: | 200 () |
Funded by: | Other |
Allocation: | Randomized |
Masking |
Clinical Trial Dates
Start date: | Sep 01, 2005 | |
---|---|---|
Primary Completion: | Aug 31, 2020 | |
Completion Date: | Aug 31, 2020 | |
Study First Posted: | Sep 07, 2005 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Apr 26, 2007 |
Sponsors / Collaborators
Location
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
Maximum Age: | 75 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
Inclusion Criteria:
Healthy adults (ASA 1-2) for scheduled surgery under general anesthesia with propofol
Exclusion Criteria:
* pregnant
* sedative or analgesic drug 24h before surgery
* allergy with drug used in the study
* difficulty of communication
* absence of informed written consent
Healthy adults (ASA 1-2) for scheduled surgery under general anesthesia with propofol
Exclusion Criteria:
* pregnant
* sedative or analgesic drug 24h before surgery
* allergy with drug used in the study
* difficulty of communication
* absence of informed written consent
Primary Outcomes
-
After prophylactic solution, evaluation of the pain caused by injection of propofol with a four-point scale before lose of consciousness
Secondary Outcomes
-
Explicite and implicite memory of pain immediately after surgery and on day one
-
Adverse effects
More Details
NCT Number: | NCT00146926 |
---|---|
Other IDs: | 2004.367 |
Study URL: | https://clinicaltrials.gov/study/NCT00146926 |
Last updated: Sep 29, 2023